Synapse - Hematology-Oncology Fellows

Results (4494)

Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia

Meeting Abstract

Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
Blood (2019)

Fulltext@MSK | Save

A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma

Meeting Abstract

Khan, N.; Shustov, A. R.; Khimani, F.; Shadman, M.; Cassaday, R. D.; Ruan, J.; Moskowitz, A. J.; Zelenetz, A. D.; Noy, A.; Straus, D. J.; more...
Blood (2019)

Fulltext@MSK | Save

Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)

Meeting Abstract

Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
Blood (2019)

Fulltext@MSK | Save

MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy

Meeting Abstract

Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy

Meeting Abstract

Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
Blood (2019)

Fulltext@MSK | Save

Younger patients with newly diagnosed FLT3-mutant AML treated with crenolanib plus chemotherapy achieve adequate free crenolanib levels and durable remissions

Meeting Abstract

Goldberg, A. D.; Coombs, C. C.; Wang, E. S.; Walter, R. B.; Karanes, C.; Vigil, C. E.; Messahel, B.; Stone, R. M.; Collins, R. H.
Blood (2019)

Fulltext@MSK | Save

Aberrant responsiveness of erythropoiesis to iron deficiency in polycythemia vera

Meeting Abstract

Feola, M.; Moskop, D.; Terra, N.; Park, Y. C.; Dunbar, A.; Levine, R. L.; Hoffman, R.; Ginzburg, Y.
Blood (2019)

Fulltext@MSK | Save

Comparative somatic mutational profiling of CD34+ hematopoietic precursors (HSC) and circulating endothelial cells (CEC) in patients with primary myelofibrosis (PMF)

Meeting Abstract

Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; Malagola, M.; Re, F.; Cattina, F.; D'Adda, M.; Rossi, G.; Zollner, T.; more...
Blood (2019)

Fulltext@MSK | Save

Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow based flow cytometry for tracking measurable residual disease (MRD) in patients with multiple myeloma

Meeting Abstract

Eveillard, M.; Rustad, E. H.; Roshal, M.; Zhang, Y.; Ciardiello, A. K.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
Blood (2019)

Fulltext@MSK | Save

Dual driver mutant BCR-ABL1-negative myeloid neoplasms: Multicenter clinicopathologic and genomic analysis

Meeting Abstract

Epstein-Peterson, Z. D.; Tripodi, J.; Arcila, M. E.; Sen, F.; Najfeld, V.; Mascarenhas, J.; Hoffman, R.; Rampal, R. K.
Blood (2019)

Fulltext@MSK | Save